our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 27 June 2016

    TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States
  • 23 June 2016

    Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product
  • 1 June 2016

    Antares Pharma Announces Update to Quickshot Testosterone Program
  • 24 May 2016

    Antares Pharma will be attending the BIO International Convention June 6-9 in San Francisco. We look forward to meeting with you at our exhibition booth #5778!
  • 9 May 2016

    Antares Pharma Reports First Quarter 2016 Financial and Operating Results
  • 2 May 2016

    Antares Pharma to Host First Quarter Operating and Financial Results Conference Call

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>